Sign inJoin waitlistJoin the waitlist

IW

Ian Walters

Hematology & Oncology

Credentials: ·

Research

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
Hepatology · 2014 · 286 citations
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Journal of Hepatology · 2017 · 195 citations
Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma
Clinical Cancer Research · 2011 · 128 citations

Richard Finn
3 papers
Anthony El-Khoueiry
2 papers
Ahmad Awada
1 paper · 1 as a fellow
Anthony Olszanski
1 paper
Blase Polite
1 paper
Bruce Brockstein
1 paper
Bubu Banini
1 paper · 1 as a fellow
Charissa Chang
1 paper
Charles Rudin
1 paper
Christian Meyer
1 paper
DD
David D'Adamo
1 paper
Diana Hanna
1 paper